Cochrane News

Subscribe to Cochrane News feed
Updated: 4 hours 34 min ago

Help Cochrane Crowd reach one million classifications!

Wed, 10/12/2016 - 20:28

You can make a difference as a citizen scientist

Cochrane Crowd, Cochrane’s new citizen science platform, is a global community made up of volunteers who are helping to identify the research needed to support informed decision-making about healthcare treatments. Cochrane Crowd has reached 900,000 individual classifications of reports of randomized controlled trials (RCTs) eligible for Cochrane’s Central Register of Controlled Trials (CENTRAL), helping Cochrane Review authors around the world to find the evidence they need for their reviews. Every contribution counts – and we’d like your help reaching one million classifications before the year is done.

Just 60 seconds a day can make a difference
In the last 20 years research output has grown exponentially, making it really difficult to keep up with the evidence. As a Cochrane citizen scientist, you would be helping us to identify and describe the research that may be very important in helping us to determine whether a treatment works, or whether a diagnostic test is accurate.

No previous experience required, you can start now or read some frequently asked questions.

Together we can reach 1 million classifications screened!

Wednesday, October 12, 2016

Cochrane's 2016 Annual General Meeting: 25 October 2016, Seoul

Wed, 10/12/2016 - 20:24

Cochrane’s Steering Group and Senior Management Team invite you to attend the Annual General Meeting (“AGM”) on Tuesday 25 October 2016. The meeting will be held at the Grand Hilton Seoul, at the 24th Cochrane Colloquium in Seoul, Republic of Korea.
Cochrane is a registered charity in the United Kingdom and must adhere to the legal requirements governing UK charities; one of these requirements is to hold an annual meeting of members. Currently, Cochrane’s members are its registered Groups (entities): Centres, Fields, Methods Groups, and Review Groups; and one person from each Group is expected to attend the AGM.

The full list of business to be conducted at this AGM-special session is set out in the Agenda together with the attachments to the Agenda.
Item 14 on the Agenda is an open discussion, during which any attendee at the AGM will have the opportunity to ask members of the Steering Group and Central Executive’s senior management any question about the organization, its strategic direction, management, and funding. To facilitate discussion, attendees are encouraged to submit their questions in advance using the designated Colloquium website form. Any member of the Cochrane community who is not attending the AGM or Colloquium is also invited to submit questions here and they will either be answered at the meeting, time permitting, or in writing following the meeting.

This is not your only opportunity to ask questions of Cochrane’s leadership. There will be an informal lunch meeting hosted by the Steering Group Co-Chairs Lisa Bero and Cindy Farquhar and CEO Mark Wilson from 13:00 -13:50 on 25 October, to which Colloquium attendees are cordially invited. This will provide another, more informal opportunity for engagement.

Thursday, October 13, 2016

Seoul Colloquium news

Tue, 10/11/2016 - 04:00

Cochrane Colloquia are our annual flagship events, bringing together Cochrane contributors from around the world to discuss, develop and promote Cochrane, and help shape its future.

The 2016 Cochrane Colloquium will be held in Seoul, South Korea from 23-27 October. For full information regarding the Colloquium, please visit the website.

  • Key information
  • Latest news
  • Plenaries, speakers and symposia
Key information:Latest news:
  • Sign-up for the Anne Anderson Walk
    The walk around Gyeongbokgung (Gyoengbok Palace) is a fundraising event for the Anne Anderson Award fund. The walk is on Wednesday 26 October at 14:30. The tour guides have been provided gratis. If you would like to sign-up for the walk, you can do so here. To donate to the award fund, click here.

  • 2016 Annual General Meeting
    Cochrane’s Annual General Meeting will be held on Tuesday 25 October, at the Colloquium. Find out more, here.

  • Sign-up now open for the full Colloquium schedule
    Sign-up for all the sessions you want to attend and create your own personal schedule for the Colloquium! You can also export the schedule to your online calendar. We'll be launching the Colloquium app in early October that will sync with your personal schedule. Details of the poster sessions are being finalised now and will be available from 21 September. 

  • Very limited room availability at the Grand Hilton
    As of 25 August, we have been advised that very few rooms are available. We have removed the online reservation page - please contact the Hilton directly (via 
     or T +82-2-2287-8428) to check if there are any rooms available.
Plenary 1: Overdiagnosis and overtreatment in health care

In this session, the role of evidence-based health care and systematic reviews in limiting overdiagnosis and oversue will be discussed, including realignment of disease definition; quantification and monitoring of overdiagnosis; sensitisation of health professionals and patients; provision of balanced information on risk and benefits intervention; and the implications for Cochrane.


  • Alexandra Barratt, Professor of Public Health, School of Public Health, University of Sydney

  • Rita F. Redberg, Editor, JAMA Internal Medicine. Professor of Medicine, Division of Cardiology, University of California, San Francisco

  • Jenny Doust, Professor of Public Health, Faculty of Health Sciences and Medicine, Bond University

Plenary 2: Challenges and different approaches to improve the quality, timeliness and usability of Cochrane Reviews

The speakers in the plenary session have been asked to describe their experiences in making challenging decisions regarding the quality and usability of Cochrane reviews. Different perspectives and lively debate will be sought with particular focus on potential initiatives that are being explored and are consistent with the CEU vision for high quality and timely Cochrane Reviews that meets the needs of end-users and informs clinical care and health policy.


  • James Thomas, Project Transform, Cochrane. Director of the EPPI-Centre’s Reviews Facility, Department of Health, England

  • Karla Soares-Weiser, Deputy Editor in Chief, Cochrane Library & Cochrane Innovations

  • Marguerite Koster, External Member, Cochrane Steering Group

  • Harriet MacLehose, Senior Editor, Cochrane Library

  • Claire Glenton, Director, Cochrane Norway

Plenary 3: Data transparency: where are we and what can we get?

Pressure to increase transparency of data in clinical research is growing as scientific academies, regulatory agencies, funders and international organisations join the call for more data transparency. In this session, recent issues in the open data movement, data access policies and its impact on health care are discussed. Some examples of the impact of lack of transparency in East Asia will highlighted.


  • Kay Dickersin, Director, Cochrane United States. Director, Johns Hopkins Center for Clinical Trials & Evidence Synthesis

  • Byung Joo Park, Professor, Department of Preventive Medicine, Seoul National University College of Medicine

  • Lesley Stewart, Director, Centre for Reviews and Dissemination, University of York

  • Rintaro Mori, Director, Cochrane Japan. Head of Department National Center for Child Health and Department of Clinical Epidemiology

Annual Cochrane Lecture: Four challenges for EBM and Cochrane’s future

Since the term evidence based medicine (EBM) was coined over 20 years ago it has had a remarkable global influence. But EBM is not a static set of concepts, set in stone tablets in the 1990s; it is a young and evolving discipline. The fundamental concept of systematic reviews – providing a periodic summary of all controlled trials to aid clinical care – may have changed little since the birth of Cochrane. However, how to best provide and apply these in practice continues to develop.

In this year’s Cochrane Lecture, Paul Glasziou will propose four areas requiring renewed or ongoing attention:

  1. Improve dialogue between “evidologists” and clinicians
  2. Treatment is the patient’s decision: support and promote shared decision making
  3. Take non-drug interventions as seriously as pharmaceuticals
  4. Sustain investment in automating evidence synthesis 


  • Paul Glasziou, Professor, Evidence-Based Medicine at Bond University; Chair, International Society for Evidence-Based Health Care

#CochraneTech Symposium: The new ecosystem for evidence synthesis

Cochrane’s technological innovations are set to transform the way evidence for health is created and used. Join us at the #CochraneTech Symposium in Seoul to discover first-hand the emerging Cochrane ecosystem for evidence synthesis.

We’re preparing an exciting morning of talks and discussion centred around how Cochrane is using its technology to help both prepare systematic reviews more efficiently but also better deliver outputs to our end-users. The #CochraneTech Symposium is the premier event for those interested in the application and integration of existing and emerging technologies in the production of Cochrane systematic reviews and evidence synthesis in health care.

Since the inaugural #CochraneTech Symposium in Québec City in 2013 several ambitious technological strategies have been pursued by Cochrane, and we welcome you to join us in exploring this new ecosystem for evidence synthesis.

Methods Symposium: Living Systematic Reviews: Methods, Opportunities and Challenges

Living systematic reviews, as online summaries of healthcare research that are updated as new research becomes available, offer exciting possibilities in the new evidence ecosystem. Momentum is building around the living systematic review concept: a number of approaches are being piloted and Cochrane is at the forefront of these efforts. Living systematic reviews differ from traditional systematic reviews in several ways that have important implications for review methods and processes, affecting authors, editors and publishers. 

At this interactive symposium, we will explore what living systematic reviews actually are and their implications for Cochrane. Participants will hear from those who have been piloting living systematic review methods and will be invited to contribute their expertise as we explore the implications of LSRs for review methods and review production processes, plus the enablers within Cochrane to support their introduction.

Knowledge Translation (KT) Symposium

In 2016 Cochrane is embarking on the development of a Knowledge Translation (KT) Strategy, which will inform, facilitate and coordinate KT activities within Cochrane. We hope this strategy will scope knowledge translation activities for Cochrane, build on the Strategy to 2020 goals and provide a framework and co-ordination to support those who are undertaking knowledge translation activities in Cochrane. This framework will guide our knowledge translation work and ensure quality of outputs. We hope to establish mechanisms for better coordination of knowledge translation work within Cochrane so that organisational learning in this area flows through Cochrane.

In this symposium we will be presenting the current draft of Cochrane’s KT strategy. There will be brief presentations on the work around the strategy, an opportunity for discussion and input into further development of the strategy and the implementation plans accompanying it and what it will mean for knowledge translation in Cochrane.

Look forward to seeing you in Seoul in October!

Tuesday, October 11, 2016

Cochrane Russia helps to prepare new systematic reviewers

Thu, 10/06/2016 - 18:23

Successful two-day workshop increases awareness of evidence-based medicine and Cochrane

The Kazan Federal University, the home of Cochrane Russia, hosted a two-day workshop on the first step of conducting a systematic review; from registering the title to drafting the protocol. The workshop was intended for health professionals, researchers, academics, and teachers, willing to commit to development of Cochrane systematic reviews as authors or peer reviewers, and to Cochrane activities in Russia.

The event was a great success, with 15 graduating the two-day course and significant media coverage of the event and Cochrane’s work. Several news and TV stations covered the event, helping to increase the profile of Cochrane in Russia and inform the general public about the importance of evidence-based medicine.

Selected news coverage:
•    В КФУ прошла уникальная для России школа доказательной медицины Кокрейн
•    В  "Прессуха Медиа Служба"
•    В новостном блоке  сайта КФУ
•    Новости КФУ от 08.09.2016
•    UniverSmotri

Tuesday, October 11, 2016

Cochrane in the news: October 2016

Tue, 10/04/2016 - 19:04

A round-up of selected recent coverage citing, discussing, and presenting health evidence - updated throughout the month.



News-Medical.Net featured an interview with Cochrane Reviewer and discusses the Cochrane approach to evidence and recent evidence on Vitamin D for asthma attacks.

Cochrane contributor Hilda Bastian blogs on PLoS in memory of longtime Cochrane contributor Andrew Herxheimer and shares the untold story of his father, Herbert Herxheimer.

En route
, Air Canada’s in-flight magazine, spotlight frequent flyer Peter Tugwell, Coordinating Editor of Cochrane Musculoskeletal.

Sexually Transmitted Infections BMJ blog
post focuses on recent Cochrane Review on chlamydia.

Professor Edzard Ernst draws on Cochrane Evidence in his post on homeopathy in his post in Spector Health.


Article on the Vox looks at project aimed at building a foundation of critical thinking skills about health in schools.

Friday, October 7, 2016

Use of Cochrane Reviews to inform WHO guidelines

Fri, 09/30/2016 - 15:34

So far this year, 90% of the 2016 WHO guidelines contain Cochrane Evidence

Cochrane exists so that healthcare decisions get better. During the past 20 years, Cochrane has helped to transform the way health decisions are made. Cochrane contributors - 37,000 from more than 130 countries - work together to produce credible, accessible health information that is free from commercial sponsorship and other conflicts of interest. Many of our contributors are world leaders in their fields - medicine, health policy, research methodology, or consumer advocacy - and our groups are situated in some of the world's most respected academic and medical institutions. Our work is recognized as representing an international gold standard for high quality, trusted information.

Cochrane has been a non-governmental organization in official relations with the World Health Organization (WHO) since 2011. WHO develops global health guidelines, which are of a high methodological quality and are developed through a transparent, evidence-based decision-making process. Ensuring there is an appropriate use of evidence within these guidelines, represents one of the core functions of WHO.

The percentage of Cochrane Reviews used in WHO guidelines have been steadily raising. So far for 2016, Cochrane Reviews have been included in 90% of the WHO guidelines, which surpasses last year’s 75% inclusion rate. As of 26 September 2016, 474 reviews from Cochrane Review Groups have been used to inform 160 World Health Organization accredited guidelines and other evidence-based recommendations published between 2008 and 2016. Of the 160 WHO guidelines and other evidence-based recommendations that have used Cochrane reviews to inform their guidance, 14 have used over 10 reviews in any one guideline.

Cochrane’s partnership with WHO is helping to put our high quality evidence into guidelines that will have an impact upon health policies and clinical practise worldwide. It’s also a testament to the important and hard work that many in the Cochrane community are putting forward.

Thursday, October 6, 2016

Monash University seeks Research Fellow (Evidence Review) - Melbourne, Australia

Fri, 09/23/2016 - 03:22

Monash University Mental Health and General Practice is seeking a Research Fellow (Evidence Review)

Closing date: 22 November

Job No: 552703
Faculty of Medicine, Nursing and Health Sciences
School of Primary Health Care
Department of General Practice
Location: Notting Hill
Employment Type: Part-time (0.8)
Duration: 12 month fixed-term appointment
Pro-rata of $62,271 - $84,513 pa Level A PhD
(plus 9.5% employer superannuation)

For complete information on the position and how to apply, please see the full posting on the Monash website.

Tuesday, November 22, 2016 Category: Jobs

Translated Cochrane evidence

Fri, 09/16/2016 - 04:00

Bringing you Cochrane evidence in 13 different languages
Making Cochrane evidence accessible to non-English speakers is a priority for us. More than 4,000 translations of Cochrane Review plain language summaries/abstracts have been published so far this year. Translation activities are led by local Cochrane groups and their translator communities, the majority of which are volunteer based. Due to the length of Cochrane Reviews, our teams focus on the abstract and or the Plain Language Summary.
Find Cochrane evidence in different languages: Cochrane evidence is currently translated into 13 languages: Croatian, French, German, Japanese, Korean, Malay, Polish, Portuguese, Russian, Simplified Chinese, Spanish, Tamil and Traditional Chinese. Each language has its own version of; you can view translations by clicking on the languages that appear across the top of each page.

Cochrane Podcasts in different language: Cochrane podcasts offer a short summary of a recent Cochrane review and have been recorded in 33 languages.
Most translated Reviews: The links below will take you to the English language version of our most translated Reviews. Languages these Reviews have been translated into are listed across the top of the page. To read the Review in another language, simply click on the language and it will take you to the translation.
· Interventions for preventing obesity in children
· Electronic cigarettes for smoking cessation and reduction
· Vitamin C for preventing and treating the common cold
· Continuous support for women during childbirth
Our translation achievements for the first half of 2016 in an infographic:

Monday, November 21, 2016

Featured Review: Population-level interventions in government jurisdictions for dietary sodium reduction

Thu, 09/15/2016 - 17:52

National government initiatives have the potential to achieve population-wide reduction in salt intake

In almost all countries worldwide, most people eat too much salt. This can cause high blood pressure, which can lead to health problems, such as heart disease and stroke. To reduce the amount of salt eaten, governments in many countries have developed national salt reduction initiatives. These initiatives may be individually oriented, such as providing education about salt, or structurally oriented, to improve or offset the deficiencies which prevent people from obtaining food with lower salt. As the number of population-based initiatives to reduce salt rise worldwide, it is important for policy-makers to identify which population-level intervention are impactful and cost-effective.

A team of Cochrane authors based in Australia and Canada worked with Cochrane Public Health to examine whether national salt reduction initiatives have been effective in reducing the amount of salt consumed in those populations. Fifteen national initiatives including more than 260,0000 people were included, with 10 initiatives providing sufficient date for quantitative analysis. These were mostly conducted in high-income countries. The quality of the data was rated to be very low given the nature of the interventions does not lend to using controlled study design.

Population-level interventions in government jurisdictions for dietary sodium reduction have the potential to result in population-wide reductions in salt intake from pre-intervention to post-intervention, particularly if they have more than one intervention activity and incorporate interventions of a structural nature (e.g. large-scale efforts to lower the salt content of food products at the time of production), and particularly amongst men. Implementation of future initiatives should embed more effective means of evaluation to help us better understand the variation in the effects.

This Cochrane Review excluded a larger number of national salt reduction strategies because the data lacked pre and/or post data points which are needed to examine the impact of the intervention. There were 15 included initiatives in the review but with a wide variation in the elements they included, as well as the quality of evidence in their evaluation. For these reasons, it is difficult to interpret the current evidence and warrants more research. This review provides some evidence that national sodium reduction initiatives that are multi-component and include activities of a structural nature, such as policies to lower the salt levels in food in specific settings, appear to be more effective than single-component initiatives, such as information campaigns.

Read the full Cochrane Review

Visit the Cochrane Public Health website

Friday, October 7, 2016

Cochrane Podcasts

Mon, 09/05/2016 - 04:00

Cochrane podcasts deliver the latest Cochrane evidence in an easy to access audio format, allowing you to stay up to date on newly published reviews wherever you are.

Each Cochrane podcast offers a short summary of a recent Cochrane review from the authors themselves. They have been recorded in 33 languages and are brief, allowing everyone from healthcare professionals to patients and families to hear the latest Cochrane evidence in under five minutes.

You can view and search our entire catalogue of hundreds of podcasts or subscribe via iTunes for the latest updates.

Whether you listen in your office, on your daily commute or even in the bath, Cochrane podcasts offer a quick and easy way to keep up with the latest evidence from the Cochrane Library.

Wednesday, November 9, 2016

What are systematic reviews?

Fri, 08/26/2016 - 00:27


"What are systematic reviews?"

If you’re a Cochrane contributor and have ever attempted to explain Cochrane’s work to someone, chances are you’ve tried to answer this question. And if you’re reading this because you’re new to Cochrane and the work we do, you may be wondering about this too.

Thanks to a team of creative colleagues from Cochrane Consumers and Communication, we’re pleased to share a video resource which answers this question clearly and simply for people who may not be familiar with the concept of systematic reviews: what they are, how researchers prepare them, and why they’re an important part of making informed decisions about health - for everyone. You can find this video on Cochrane’s YouTube channel, and we hope you’ll share and spread the word about the importance of evidence!

Tuesday, April 4, 2017

Cochrane evidence on Tumblr

Mon, 08/01/2016 - 16:16

Browse through our Tumblr account and get a visual dose of Cochrane evidence!

Tumblr is a microblogging social networking website – a place where people post images and animated graphics. On our Cochrane Tumblr account, you can view visual summaries of Cochrane evidence.

If you have a Tumblr account, you can follow us to add Cochrane evidence to your feed. If you don’t have a Tumblr account, just stop by and browse by health area or language – we have posts in seven different languages!

Cochrane Tumblr: 

Tuesday, October 25, 2016

International Clinical Trials' Day 2017

Thu, 05/19/2016 - 04:00

International Clinical Trials' Day is celebrated around the world each year on or close to 20 May, commemorating the day in 1747 on which James Lind began the first known controlled trial, comparing different treatments for scurvy then in common use among sailors in the British Royal Navy. (Watch a video explaining the trial to see history in the making.) International Clinical Trials' Day seeks to raise awareness of the importance of research to health care, and draw attention to ways in which the research can become more relevant to practice.

The European Clinical Research Infrastructures Network (ECRIN)helps to co-ordinate the annual commemoration, providing a focal point for international events, meetings, debates, and other celebrations of clinical research. The highlight of each year is a series of public lectures and discussions, held in a different European city. The 2017 celebrations are taking place on May 19th in Lisbon, Portugal. A range of speakers will present a variety of relevant topics, including ‘Data sharing and reuse: attitudes and practices in multinational clinical research’, with healthcare professionals and researchers from across Europe in attendance.

Learn about Cochrane systematic reviews and how clinical trials are used:

As part of our own commemoration of International Clinical Trials’ Day, Cochrane is highlighting a series of recent reviews using clinical study data and regulatory reports, as well as published reports in peer-reviewed journals:

Additional plerixafor to granulocyte colony-stimulating factors for haematopoietic stem cell mobilisation for autologous transplantation in people with malignant lymphoma or multiple myeloma

Blood pressure lowering efficacy of renin inhibitors for primary hypertension

Interventions for cutaneous molluscum contagiosum

And learn more about the issues relevant to clinical research in the latest of our commemorating the event.

Post and find other relevant information and resources on Twitter by using the hashtag #ICTD2017.

Friday, May 19, 2017